Scinai Immunotherapeutics (2F50) Q1 2026 Earnings Report
DE:2F50 Q1 2026 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 7.13
DE:2F50 Q1 2026 Revenue Results
- Actual Revenue
- EUR 437.85K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -16.12%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 06/10/2026
- Time
- Before Open
- Conference Call
- Wednesday, June 10, 2026
DE:2F50 Upcoming Earnings
Scinai Immunotherapeutics's next earnings date is estimated for December 2, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2F50 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Dec 02, 2026 | 2026 (Q3) | ―- | -42.46 | ― | ― |
| Aug 20, 2026 | 2026 (Q2) | ―-3.28 | -15.73 | 79.16% (+12.45) | |
| Jun 10, 2026 | 2026 (Q1) | ―0.00 | -7.13 | 100.00% (+7.13) | |
| Apr 01, 2026 | 2025 (Q4) | ―8.57 | -7.13 | 220.31% (+15.70) | |
| Dec 02, 2025 | 2025 (Q3) | ―-42.46 | 0.02 | -225919.05% (-42.48) | |
| Sep 02, 2025 | 2025 (Q2) | ―-15.73 | -0.02 | -87750.00% (-15.71) | |
| May 30, 2025 | 2025 (Q1) | ―-1.07 | -0.01 | -11840.00% (-1.06) | |
| May 07, 2025 | 2024 (Q4) | ―-7.13 | -0.01 | -79480.00% (-7.12) | |
| Nov 22, 2024 | 2024 (Q3) | ―0.02 | 0.18 | -89.50% (-0.16) | |
| Aug 15, 2024 | 2024 (Q2) | ―- | -0.03 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
